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Cervical radiculopathy has become an increasing problem worldwide. Conservative treatment options 
have been recommended in many reviews on cervical radiculopathy, ranging from different types of 
physiotherapy to waiting for remission by natural history. No multimodal pain management concept 
(MPM) on an inpatient basis has been evaluated. This study aimed at showing the positive short-term 
effects of an inpatient multimodal pain management concept with focus on cervical translaminar 
epidural steroid injection for patients with cervical radiculopathy. 54 patients who had undergone 
inpatient MPM for 10 days were evaluated before and after 10-days treatment. The NRS (0–10) value 
for arm pain could be reduced from 6.0 (IQR 5.7–6.8) to 2.25 (IQR 2.0–3.1) and from 5.9 (IQR 4.8–6.0) 
to 2.0 (IQR 1.7–2.6) for neck pain. Neck pain was reduced by 57.4% and arm pain by 62.5%. 2 days after 
epidural steroid injection, pain was reduced by 40.1% in the neck and by 43.4% in the arms. MPM seems 
to be an efficient short-term approach to treating cervical radiculopathy. Cervical translaminar epidural 
steroid injection is an important part of this concept. In the absence of a clear indication for surgery, 
MPM represents a treatment option.
The incidence of neck pain in clinical studies ranges between 10.4% and 71.5%, and the annual prevalence is 
estimated to vary between 30% and 50%1–6. 2009; Hoy 2010] The average annual age-adjusted incidence rates 
per 100,000 population for cervical radiculopathy are 83.2 and age-specific 202.9 in the age group 50–54 years7. 
Cervical radiculopathy has become an increasing problem over the last years. E.g. in Germany, the number of 
patients with cervical radiculopathy and inpatient treatment doubled from 2005 to 20158.
The degenerative changes mainly affect the lower levels of the cervical spine, in particular C5/C6 as well as C6/
C7 and rare C7/Th1 or C4/C5. In our clinical experience, radiologically elevated findings in native and sectional 
image diagnosis (CT, MRI) correlate only partially with clinical findings. Cervical radiculopathy is resulting from 
nerve root dysfunction, which may be caused by several reasons, most commonly by disc herniation and spinal 
foraminal stenosis9. In addition, there may be other reasons for upper extremity pain than radiculopathy. Muscles, 
ligaments or cervical facet joints may be responsible for pain in the neck or in the upper extremities1, 3, 10, 11. 
‘Clinically, it is characterized by arm pain, in some cases paraesthesia and eventually reduced muscle strength, 
altered sensation and impairment of deep tendon reflexes’12, 13.
The age group with the highest risk of developing cervical radiculopathy in the USA and European countries 
is that of people aged between 35 and 49 years14.
Most authors have viewed pain episodes over a person’s lifetime as common relapses. Women and residents of 
high-income countries or urban areas have a higher risk of developing cervical radiculopathy14.
Furthermore, neck pain has a significant impact on socioeconomic factors and on costs of public health ser-
vices15–17. A report describing the U.S. health status regarding diseases and risk factors, neck pain ranked number 
4 between 1990 and 20101, 15.
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In addition, Nolet et al. proposed that neck pain contributes to poor physical quality of life in the future17. 
The costs of public health services are steadily increasing, while the number of effective treatment options is still 
limited; therefore, it is very important to find the right treatment for each individual patient as soon as possible18.
The number of surgical interventions for cervical radiculopathy and degenerative conditions have grown rap-
idly in the United States19, 20.
This increase may be due to the low reimbursement of conservative treatments by health care providers and 
the lack of sufficient evidence for conservative treatment options for neck and arm pain. In Germany for example, 
the inclusion criteria for an inpatient multimodal pain management concept (MPM) are so tight, that in our daily 
clinical experience only 20% of patients can benefit from it. The therapeutic concepts available are very hetero-
geneous and can hardly be compared. In our opinion, in the absence of a clear indication for surgery, intensive 
conservative treatment should be provided, and all conservative treatment options should be exhausted prior 
to any spine surgery21. The mostly non-surgical intervention described in the literature so far is epidural steroid 
injection, which is still listed as ‘off-label’ use22. Nevertheless, literature reports have often described the success 
of this treatment method for pain relief from radicular symptoms1, 3, 10, 11, 23–31. Injection techniques have become 
an important tool for treating spinal pain24.
In the case of low back pain, injection therapy is often accompanied by multimodal treatment such as physical 
therapy and psychological counselling to avoid pain chronification32. MPM has been shown to be a very beneficial 
treatment option for avoiding surgery and reducing pain in patients with radicular nerve root compression33–35. 
Beside the injections, conservative treatment options have been recommended in many reviews on cervical radic-
ulopathy, ranging from different types of physiotherapy to waiting for remission by natural history. There are 
studies to show the efficacy of training programs on upper extremity pain in patients with chronic neck in the 
short and long term36–38.
However, no multimodal treatment concept on an inpatient basis has yet been evaluated9, 39, 40. Only little is 
known about the use of multimodal pain management concepts in the case of cervical radiculopathy. Therefore, 
it is important to show the effectiveness of a multimodal pain management concept and particularly the benefits 
of epidural steroid injection within this concept. Due to the nerve root injections, pain and symptoms can be 
reduced faster and the patient can benefit from the exercise programs and the behavioural approach within the 
hospital stay. The multimodal approach including orthopaedic and psychological interventions helps to stop the 
vicious circle.
Aim of the study
This study aimed at showing the short-term effect of an inpatient multimodal therapeutic concept based on drug 
injections – with particular focus on cervical translaminar epidural steroid injection – for patients with cervical 
radiculopathy.
Methods
This non-randomized, unblended, prospective, clinical study included male and female patients with cer-
vical radiculopathy, who had been treated according to a multimodal therapeutic concept at the Department 
of Orthopaedics of the University Medical Centre Regensburg between March 2015 and September 2015. 
Participation in the study was voluntary. Inclusion criteria were neck and arm pain >4 on a numeric rating 
scale (NRS 0–10) and clear signs of radiculopathy, which means radiating arm pain, positive Spurling test and 
according MRI findings41. In addition, to be included in the follow-up, patients had to have participated in at 
least two psychological sessions during therapy. An absolute indication for surgery had to be excluded and a clear 
indication for MPM was required. That means at least 6 weeks of pain and failed outpatient treatment. Exclusion 
criteria were cervical surgery before treatment, myelopathy, tumours with spinal involvement, and congenital 
spinal deformities. In addition, patients had to speak German language to be able to take part in the psychological 
behavioral education lessons. Since this was a single-arm study, no control group was available. Cervical nerve 
root injections may have some severe side effects; therefore, placebo injections cannot be justified42. The study was 
approved by the Ethics Commission of the University of Regensburg (24 February 2015, reference no. 16-101-
0014) and carried out in accordance to the approved guidelines of the Helsinki Declaration of 1975. A written 
informed consent was obtained from all study participants. The study is registered on 22.02.2017 in the German 
Clinical Trials Register (Deutsches Register Klinischer Studien; DRKS) under the number DRKS00011788 
(WHO register).
Patients. The patients were recruited for MPM treatment in our outpatient clinic when fulfilling the described 
criteria. The inclusion in the study was done on their first day of hospital stay by the first author. 54 of initially 69 
patients remained after evaluating the exclusion criteria. 6 of the 11 excluded patients had received primary sur-
gery, 4 showed myelopathy in the MRI, and 5 declined participation. (Fig. 1) The average age of excluded patients 
is 52 years (32–63), 7 female and 4 male patients.
In all patients, diagnosis of cervical radiculopathy was made by means of patient history and clinical symp-
toms prior to treatment. All 54 patients also showed relevant findings in the MRI (disc herniation or recess steno-
sis), so that injection-based therapy represented an appropriate treatment option. The age of the included patients 
was between 29 and 79 years. The relevant demographic data can be seen in Table 1. Only 6 patients (11.1%) had 
experienced neck and arm pain for just 6 weeks, 19 (35.2%) for more than 3 months and 18 (33.3%) for more 
than 2 years. The remaining 11 (20.4) patients had experienced pain between 6 and 12 weeks before treatment. 
All patients had neck and arm pain, 52.6% of them also pseudo-radicular pain and 47.4% clear radicular pain.
Intervention. This multimodal pain management concept has already been published several times by the 
author for low back pain32 and has now been adapted for patients with cervical radiculopathy.
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On average, each patient received two injections daily, one in the morning and one at noon. The injections 
contained 0.5% Mepivacaine, a cervical spinal nerve root analgesic (CSPA), which was injected into the affected 
nerve root in ‘free-hand technique’21, 43. Additional treatment consisted of 1 cervical epidural translaminar injec-
tion per hospital stay conducted in ‘loss-of-resistance technique’ under X-ray control in 2 planes in the operating 
theatre21, 43, 44. Cervical epidural translaminar injections contained 40 mg of triamcinolone and the contrast agent 
solutrast 250 (Fig. 2). The other applications have already been described by the author18, 32: ‘Physiotherapy and 
sports therapy as part of inpatient MPM includes group exercises and aqua training; accompanying measures 
consist of electrotherapy for muscle relaxation and thermotherapy. In addition, patients are instructed in progres-
sive muscle relaxation according to Jacobsen and take part in coordination training45. The most effective exercises 
are isometric exercises for strengthening the neck muscles, which is further aided by medical training therapy 
with workout equipment. The main goal is recovery of the load-bearing capacity and reduction in pain-avoidance 
behaviour. To address pain management, patients participate in psychological trainings and interviews with psy-
chologists. The success of MPM depends on accurate patient information and consultation, continuous motiva-
tion, a systematic increase of load, and permanent feedback’. Each patient had to keep a pain diary to note the pain 
score 4 times a day. The average schedule of a 10-day program is shown in Table 2.
Data. Data were recorded daily in a standardized manner. The data obtained before, during, and after treat-
ment were compared to assess the treatment success at the end of hospitalization. Besides the numerical rating 
scale (NRS) for neck and arm pain as a main evaluation criterion, the validated German version of the Neck 
Disability Index (NDI)46 was assessed at the beginning and at the end of therapy. Minimal clinically significant 
pain reduction was set to NRS 2.047–49. Treatment success was defined as NRS < 50% of the initial pain at the end 
of hospitalization50. Using the NDI, a score of < = 8% means patients with hardly any symptoms, whereas a score 
>40 stands for patients with severe problems and a higher risk of pain chronification51–55. The minimal clinically 
relevant change has ranged from 3.5% to 9.5% depending on the respective author53, 54. We used the percentage of 
8.4% applied by Jorritsma et al.55. The Hospital Anxiety and Depression Scale-German version (HADS-D) were 
evaluated only on the first day of therapy, because no changes were expected during hospitalization. Scores from 0 
to 7 are normal, scores from 8 to 10 borderline abnormal, and scores higher than 10 are abnormal for both anxiety 
and depression56, 57.
Figure 1. Flowchart of patient inclusion.
Women (n = 32) Men (n = 22) Together (n = 54)
Age (years) 58 (31–87) SD 15.1 55 (33–66) SD 8.3 57 (31–87) SD 12.8
BMI 27.9 (19.5–43.2) 28.9 (19.5–39.8) 28.32 (19.5–43.2)
HADS anxiety
normal 9 (28.1%) 
borderline 12 (37.5%) 
abnormal 11 (34.4%)
normal 9 (40.9%) 
borderline 7 (31.8%) 
abnormal 6 (27.3%)
normal 18 (33.3%) 
borderline 19 (35.2%) 
abnormal (31.5%)
HADS depression
normal 19 (59.4%) 
borderline 6 (18.8%) 
abnormal 7 (21.9%)
normal 14 (63.3%) 
borderline 4 (18.2%) 
abnormal 4 (18.2%)
normal 33 (61.1%) 
borderline 10 (18.5%) 
abnormal 11 (20.4%)
affected nerve root C5: 13 (40.6%) C6: 15 (46.9%) C7: 4 (12.5%)
C5: 8 (36.4%) C6: 10 
(45.5%) C7: 4 (18.2%)
C5: 21 (38.9%) C6: 25 
(46.3%) C7: 8 (14.8%)
Work status when 
starting treatment
working 15 (46.9%) 
ill reported 5 (15.6%) 
retired 12 (37.5%)
working 13 (59.1%) 
ill reported 7 (31.8%) 
retired 2 (9.1%)
working 28 (51.9%) ill 
reported 12 (22.2%) 
retired 14 (25.9%)
Table 1. Demographic data of the patient group (mean and range).
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To assess the effect of cervical epidural injection as conducted for triamcinolone without any local anaesthet-
ics, pain reduction was evaluated 2 days after injection58. Because these injections were only given on Tuesdays 
or Fridays, some sort of randomisation was provided on what day of hospitalisation the epidural injection was 
given. Patients were admitted to hospital from Monday to Friday. At the end of the stay all collected data were 
pseudonymized saved. Primary outcome was pain reduction >NRS 2 for arm and neck pain.
Statistical analysis. Statistical analysis was done with SPSS (IBM SPSS Statistics, Version 23.0., Armonk, 
NY: IBM Corp.). Metric variables were reported descriptively as mean and standard deviation. Statistical data 
were not normally distributed. Data were compared with the non-parametric Wilcoxon test. The level of signif-
icance was set at p < 0.05. A sample size of n = 54 resulted in 80% power to detect a significant effect, if the true 
effect size of the total population was d = 0.39, which can be considered small.
The datasets generated during and/or analyzed during the current study are available from the corresponding 
author on reasonable request.
Results
Questionnaires. The Neck Disability Index (NDI) is used to measure everyday impairment. The mean value 
at the initial examination on day 1 was 37.1%. As described above, the minimal clinically relevant change was set 
at 8.4%. There was a significant improvement (p < 0.001), 57.4% of the patients described pain reduction of more 
than 8.4%. The mean changes were 11.24% but started at −8, which means pain increase in one patient and pain 
reduction in 52% of patients.
The Hospital Anxiety and Depression Scale (HADS-D) was additionally used to detect possible psychological 
abnormalities56. The results for anxiety and depression can be seen in Table 1. During the first day assessment, 
patients were also asked about existing comorbidities. 10 patients (18.5%) stated depression, and the HADS 
showed 20% abnormalities on the depression scale. Interestingly, only 5 of these 10 patients also had an abnormal 
HADS score.
Figure 2. Typical pattern of epidural contrast agent distribution between red arrows; green arrow: needle.
Exercise Number
Group exercises 4
Aqua training 5
Neck exercises 5
Instructions on progressive muscle relaxation 3
Psychological behavioral education 3
Coordination training group 4
Table 2. Example of a 10-day schedule of physiotherapy and sports therapy as part of inpatient MPM.
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Pain. The median NRS value for neck pain was 6.0 (5.7–6.8) before treatment and 2.25 (2.0–3.1) at discharge. 
The NRS value for arm pain could be reduced from 5.9 (4.8–6.0) to 2.0 (1.7–2.6). (Table 3, Fig. 3 and 4) The 
median pain reduction at the end of treatment was 3.5 (3.1–4.1) for neck pain and 3.0 (2.7–3.8) for arm pain, 
which means a reduction in neck pain by 57.4% and a reduction in arm pain by 62.5%. Both reductions were 
statistically significant (p < 0.05). Pain reduction in women was higher than that in men, but this difference was 
not significant. As described above, the minimal clinically relevant reduction in NRS was set at 2. This value 
was reached after 4.0 (3.8–5.2) days for neck pain and after 4.0 (3.4–4.8) days for arm pain. According to the 
IMMPACT definition of treatment success with an NRS improvement of 50% at the end of hospitalization, 40 
patients (74.1%) were treated successfully for neck pain and 36 (66.7%) for arm pain50.
Cervical translaminar epidural steroid injection. In the mean, cervical translaminar epidural steroid 
injection was given on day 4, but this time point ranged between day 1 and 9. 2 days after epidural steroid injec-
tion, pain was reduced by 40.1% in the neck and by 43.4% in the arms. Adverse events were noted in the diary by 
the patients. Only 4 (7.4%) patients described some dizziness as a side effect, but no severe adverse events were 
reported.
Discussion
The study aimed at showing the positive short-term effect of an inpatient multimodal therapeutic concept based 
on drug injections for patients with cervical radiculopathy with particular focus on cervical translaminar epidural 
steroid injection.
Within this concept, we showed that neck pain improved from NRS 6.0 to 2.25 and arm pain from 5.9 to 2.0, 
and both values represent significant pain reduction (p < 0.001).
68.5% (37) of the treated patients had experienced pain for more than 3 months. Thus, avoiding pain chronifi-
cation or trying to reverse the effects is all the more important. The NDI score as a value for every day impairment 
had also improved during hospitalization.
Only single methods are usually described as treatment options. Most studies have either compared differ-
ent surgical approaches59 or the type of injection10, 24–28, 60–65. Conservative treatment options have been recom-
mended in many reviews on cervical radiculopathy, ranging from different types of physiotherapy to waiting for 
remission by natural history. However, no multimodal treatment concept on an inpatient basis has been evaluated 
so far9, 39, 40.
In times of low frequency outpatient treatment, first pain relief takes longer, bearing a high risk of pain chron-
ification. In this study, the period of the first clinically relevant success with regard to pain reduction of more than 
Women (n = 32) Men (n = 22) Together (n = 54)
Treatment days 10.0 (9.3–10.7) 10 (±1.7) 10.0 (9.4–11.0) 10.2 (±1.7) 10.0 (9.6–10.6) 10.1 (±1.7)
Neck pain on day 1 (NRS) 6.0 (5.3–7.0) 6.0 (±1.9) 6.75 (6.7–7.2) 6.4 (±1.6) 6.0 (5.7–6.8) 6.1 (±1.8)
Arm pain on day 1 (NRS) 5.75 (4.5–6.3) 5.5 (±2.1) 6.0 (4.6–6.4) 5.5 (±1.9) 5.9 (4.8–6.0) 5.5 (±2.0)
Neck pain on day of discharge (NRS) 2.25 (1.7–3.5) 2.7 (±2.1) P = 0.000 2.25 (1.8–3.1) 2.4 (±1.4) P = 0.000 2.25 (2.0–3.1) 2.6 (±1.9) P = 0.000
Arm pain on day of discharge (NRS) 1.75 (1.4–2.6) 2.0 (±1.5) P = 0.000 2.0 (1.5–3.1) 2.3 (±1.7) P = 0.000 2.0 (1.7–2.6) 2.1 (±1.6) P = 0.000
Days of hospitalization needed for 
relief of neck pain >2 (NRS) 4.0 (3.0–5.3) 4.1 (±2.0) 5.0 (4.1–5.6) 5 (±1.8) 4.0 (3.8–5.2) 4.4 (±1.9)
Days of hospitalization needed for 
relief of arm pain >2 (NRS) 4.0 (2.8–4.8) 3.7 (±2.3) 4.0 (3.5–5.5) 4.5 (±2.3) 4.0 (3.4–4.8) 4.1 (±2.3)
Table 3. Data on pain treatment of the patient group (median and interquartile range; mean and standard 
deviation).
Figure 3. Course of neck pain during hospitalization (Median and IQR).
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NRS 2 was 4.4 days for neck pain and 4.1 days for arm pain. Because of the combination of several types of con-
servative treatment and 2 injections per day, patients receive different conservative treatments over a very short 
period of time, which leads to quick pain relief and thus − in combination with psychological lessons – tries to 
avoid chronification32.
Particularly physical activation is the key to successful conservative treatment. ‘The aim of the accompanying 
methods is to preserve or restore the full capacity of the spine-stabilizing muscles, to train coordination skills and 
to learn spine friendly behaviour. Risk factors that can lead to chronic pain must be eliminated. All methods serve 
to interrupt the vicious circle of “pain−stress−malposition−pain”32. While reducing pain through injections, 
patients may take part in activating treatments as mentioned above. ‘Besides direct physical effects, the accom-
panying therapies also help to improve the affective-emotional level as well as the motor-psychomotor level by 
learning physically regulating movements. The focus is on activating methods, not on passive methods’32.
With this study, we showed that there is the wanted effect on neck and arm pain. Therefore, these data also 
support our concept of interrupting the vicious circle of ‘pain–stress–malposition–pain’. It is clear, that a restau-
ration of the full capacity of the spine-stabilizing muscles cannot be achieved after just 10 days, but this intensive 
treatment should be the cornerstone for further exercises.
Many studies show positive effects of different types of exercises. Cervical range of motion and strengthening 
exercises are typically not recommended when patients are symptomatic as these movements may exacerbate 
symptoms66. This supports our idea of reducing pain by injections first. Cervical traction and immobilization 
has been supported in some studies to calm the symptoms associated with cervical radiculopathy67. Also cervi-
cal traction may increase the dimensions of the neuroforamen by distraction. A recent prospective randomized 
clinical trial found that adding mechanical traction to an exercise protocol in patients with cervical radiculopathy 
resulted in superior outcomes (neck disability index, arm pain) when compared with exercise plus over door trac-
tion, or exercise alone68. As traction was not included in our therapy yet, further investigation of this effect within 
our concept will be interesting. It has also been shown that neck-specific exercises with and without behavioral 
approach has better results than general physical activity36.
Another important part of the MPM are the psychological lessons. Psychosocial interventions should be 
offered in addition to the medical treatment to patients to reduce the risk of chronic pain. The efficacy of such an 
interdisciplinary care has been shown69.
In this study, special focus was placed on the effect of cervical translaminar epidural steroid injection. 
Although, epidural injections have now been used for many years and are the only effective, non-operative tool 
for managing cervical radiculopathy, the use of corticosteroid is still ‘off-label’ worldwide22. In addition, many 
reports have described severe complications, but Pountos et al. stated in their review that ‘the true incidence 
of such complications remains unclear.’ The most devastating complications such as paralysis are very rare and 
have been limited to case reports64. Minor adverse events have an incidence of less than 1% and are generally 
transient42. But controversial discussions are still part of the scientific literature. There even was a Food and Drug 
Administration (FDA) warning on April 23, 2014, with regard to injecting corticosteroids into the epidural space 
of the spine70, 71. Other reviews have described cervical epidural steroid injections as ‘effective in easing pain and 
reducing the need for surgery’, although ‘the evidence of effectiveness is of very low quality, and the benefits of 
the procedure are compromised by the risks of serious complications’23, 58, 61. Furthermore, the use of non‐par-
ticulate vs. particulate steroids has been discussed. In our opinion, particulate steroids, similar to triamcinolone, 
remain locally effective far longer because the particles remain at the site of the injection21, 72. On the other hand, 
this mechanism may lead to the described severe complications because of intravascular injection73. In addition, 
Shakir et al. showed that transforaminal epidural steroid injections have similar benefits, independent of the 
type of corticosteroid formulation used (triamcinolone or dexamethasone)58. After analysis of the complications, 
the FDA recommended an interlaminar approach instead of a transforaminal approach as well as the use of 
non-particulate steroids to minimize the risk of accidental arterial uptake and neurological damage71. In our ther-
apy concept, we always use the interlaminar approach as described by Grifka et al.21. Over the past 16 years, we 
have always used triamcinolone as particulate steroid without any severe complications. In our study population, 
4 patients described some dizziness for a few hours after the injection. Because these injections are given in our 
Figure 4. Course of arm pain during hospitalization (Median and IQR).
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operating theatre, we often observe this phenomenon that is mainly caused by higher blood pressure due to the 
agitation of the patients. Thus, in our multimodal pain concept, epidural steroid injection has been a very effective 
tool for reducing pain in addition to the ‘normal’ daily injections.
The biggest limitation of this study may be the lack of a general control group. However, implementation of 
a control group is difficult when evaluating the overall concept of MPM and not just the sub-item ‘injections’. 
Moreover, study populations may have some selection bias because patients are only included after failed outpa-
tient unimodal therapy. Therefore, study populations may have a trend towards chronification. Another possible 
bias might be, that the data collection was not anonymous and therefore the patients might want to please their 
caregiver. Another limitation is the short follow-up and the effect after discharge is not known. Future studies will 
have to show the mid- and long-term effect of this therapy.
Conclusion
In summary, this study showed MPM based on injections to be an efficient treatment option for cervical radicu-
lopathy. Despite several reports on severe complications published in the literature, MPM appears to be a safe pro-
cedure, and transforaminal epidural steroid injection may be an important factor of this concept. In the absence 
of an absolute indication for surgery, this is a treatment option that could be tried before surgery.
Ethical approval and informed consent. The study was approved by the Ethics Commission of the 
University of Regensburg and carried out in accordance with the approved guidelines. Registration in Deutsche 
Register Klinischer Studien (DRKS), German Clinical Trials Register DRKS00011788.
References
 1. Manchikanti, L., Nampiaparampil, D. E., Candido, K. D. & Bakshi, S. et al. Do cervical epidural injections provide long-term relief 
in neck and upper extremity pain? A systematic review. Pain Physician 18, 39–60 (2015).
 2. Côté, P., Cassidy, J. D. & Carroll, L. The factors associated with neck pain and its related disability in the Saskatchewan population. 
Spine (Phila Pa 1976) 25, 1109–1117 (2000).
 3. Manchikanti, L., Abdi, S., Atluri, S. & Benyamin, R. M. et al. An update of comprehensive evidence-based guidelines for 
interventional techniques in chronic spinal pain. Part II: guidance and recommendations. Pain Physician 16, S49–283 (2013).
 4. Leboeuf-Yde, C., Fejer, R., Nielsen, J., Kyvik, K. O. & Hartvigsen, J. Pain in the three spinal regions: the same disorder? Data from a 
population-based sample of 34,902 Danish adults. Chiropr Man Therap 20, 11 (2012).
 5. Fejer, R., Kyvik, K. O. & Hartvigsen, J. The prevalence of neck pain in the world population: a systematic critical review of the 
literature. Eur Spine J 15, 834–848 (2006).
 6. Hogg-Johnson, S., van der Velde, G., Carroll, L. J. & Holm, L. W. et al. The burden and determinants of neck pain in the general 
population: results of the Bone and Joint Decade 2000-2010 Task Force on Neck Pain and Its Associated Disorders. J Manipulative 
Physiol Ther 32, S46–S60 (2009).
 7. Radhakrishnan, K., Litchy, W. J., O’Fallon, W. M. & Kurland, L. T. Epidemiology of cervical radiculopathy. A population-based study 
from Rochester, Minnesota, 1976 through 1990. Brain 117(Pt 2), 325–335 (1994).
 8. German Federal Office of Statistics www.gbe-bund.de. Number of Surgeries.
 9. Woods, B. I. & Hilibrand, A. S. Cervical radiculopathy: epidemiology, etiology, diagnosis, and treatment. J Spinal Disord Tech 28, 
E251–E259 (2015).
 10. Diwan, S., Manchikanti, L., Benyamin, R. M. & Bryce, D. A. et al. Effectiveness of cervical epidural injections in the management of 
chronic neck and upper extremity pain. Pain Physician 15, E405–E434 (2012).
 11. Manchikanti, L., Falco, F. J., Diwan, S., Hirsch, J. A. & Smith, H. S. Cervical radicular pain: the role of interlaminar and 
transforaminal epidural injections. Curr Pain Headache Rep 18, 389 (2014).
 12. Bono, C. M., Ghiselli, G., Gilbert, T. J. & Kreiner, D. S. et al. An evidence-based clinical guideline for the diagnosis and treatment of 
cervical radiculopathy from degenerative disorders. Spine J 11, 64–72 (2011).
 13. Kjaer, P., Kongsted, A., Hartvigsen, J., Isenberg-Jørgensen, A. et al. National clinical guidelines for non-surgical treatment of patients 
with recent onset neck pain or cervical radiculopathy. Eur Spine J (2017).
 14. Hoy, D. G., Protani, M., De, R. & Buchbinder, R. The epidemiology of neck pain. Best Pract Res Clin Rheumatol 24, 783–792 (2010).
 15. Murray, C. J., Atkinson, C., Bhalla, K. & Birbeck, G. et al. The state of US health, 1990–2010: burden of diseases, injuries, and risk 
factors. JAMA 310, 591–608 (2013).
 16. Gaskin, D. J. & Richard, P. The economic costs of pain in the United States. J Pain 13, 715–724 (2012).
 17. Nolet, P. S., Côté, P., Kristman, V. L. & Rezai, M. et al. Is neck pain associated with worse health-related quality of life 6 months later? 
A population-based cohort study. Spine J 15, 675–684 (2015).
 18. Benditz, A., Loher, M., Boluki, D. & Grifka, J. et al. Positive medium-term influence of multimodal pain management on 
socioeconomic factors and health care utilization in patients with lumbar radiculopathy: a prospective study. J Pain Res 10, 389–395 
(2017).
 19. Wang, M. C., Kreuter, W., Wolfla, C. E., Maiman, D. J. & Deyo, R. A. Trends and variations in cervical spine surgery in the United 
States: Medicare beneficiaries, 1992 to 2005. Spine (Phila Pa 1976) 34, 955–61; discussion 962-3 (2009).
 20. Angevine, P. D., Arons, R. R. & McCormick, P. C. National and regional rates and variation of cervical discectomy with and without 
anterior fusion, 1990–1999. Spine (Phila Pa 1976) 28, 931–9; discussion 940 (2003).
 21. Grifka, J., Benditz, A. & Boluki, D. [Injection therapy for cervical and lumbar syndromes]. Orthopade (2017).
 22. Pountos, I., Panteli, M., Walters, G., Bush, D. & Giannoudis, P. V. Safety of Epidural Corticosteroid Injections. Drugs R D 16, 19–34 
(2016).
 23. Beyaz, S. G. & Eman, A. Fluoroscopy guided cervical interlaminar steroid injections in patients with cervical pain syndromes: a 
retrospective study. J Back Musculoskelet Rehabil 26, 85–91 (2013).
 24. Shim, E., Lee, J. W., Lee, E., Ahn, J. M. et al. Fluoroscopically Guided Epidural Injections of the Cervical and Lumbar Spine. 
Radiographics 160043 (2016).
 25. Lagemann, G. M., Yannes, M. P., Ghodadra, A., Rothfus, W. E. & Agarwal, V. CT-Fluoroscopic Cervical Transforaminal Epidural 
Steroid Injections: Extraforaminal Needle Tip Position Decreases Risk of Intravascular Injection. AJNR Am J Neuroradiol 37, 
766–772 (2016).
 26. Nishio, I. Cervical transforaminal epidural steroid injections: a proposal for optimizing the preprocedural evaluation with available 
imaging. Reg Anesth Pain Med 39, 546–549 (2014).
 27. Bush, K. & Hillier, S. Outcome of Cervical Radiculopathy Treated with Periradicular/Epidural Corticosteroid Injections., in Pain 
Med [UNKNOWN REFERENCE TYPE].
 28. Jørgensen, S. H., Ribergaard, N. E., Al-Kafaji, O. H. & Rasmussen, C. Epidural steroid injections in the management of cervical disc 
herniations with radiculopathy. Scand J Rheumatol 44, 315–320 (2015).
www.nature.com/scientificreports/
8SCientifiC RepoRts | 7: 7866  | DOI:10.1038/s41598-017-08350-x
 29. Rathmell, J. P., Aprill, C. & Bogduk, N. Cervical transforaminal injection of steroids. Anesthesiology 100, 1595–1600 (2004).
 30. Caridi, J. M., Pumberger, M. & Hughes, A. P. Cervical radiculopathy: a review. HSS J 7, 265–272 (2011).
 31. Iyer, S. & Kim, H. J. Cervical radiculopathy. Curr Rev Musculoskelet Med 9, 272–280 (2016).
 32. Benditz, A., Madl, M., Loher, M. & Grifka, J. et al. Prospective medium-term results of multimodal pain management in patients 
with lumbar radiculopathy. Sci Rep 6, 28187 (2016).
 33. Kamper, S. J., Apeldoorn, A. T., Chiarotto, A. & Smeets, R. J. et al. Multidisciplinary biopsychosocial rehabilitation for chronic low 
back pain. Cochrane Database Syst Rev 9, CD000963 (2014).
 34. Kamper, S. J., Apeldoorn, A. T., Chiarotto, A. & Smeets, R. J. et al. Multidisciplinary biopsychosocial rehabilitation for chronic low 
back pain: Cochrane systematic review and meta-analysis. BMJ 350, h444 (2015).
 35. Flor, H., Fydrich, T. & Turk, D. C. Efficacy of multidisciplinary pain treatment centers: a meta-analytic review. Pain 49, 221–230 
(1992).
 36. Ludvigsson, M. L., Peterson, G., Dedering, Å. & Peolsson, A. One- and two-year follow-up of a randomized trial of neck-specific 
exercise with or without a behavioural approach compared with prescription of physical activity in chronic whiplash disorder. J 
Rehabil Med 48, 56–64 (2016).
 37. Ludvigsson, M. L., Peterson, G., O’Leary, S., Dedering, Å. & Peolsson, A. The effect of neck-specific exercise with, or without a 
behavioral approach, on pain, disability, and self-efficacy in chronic whiplash-associated disorders: a randomized clinical trial. Clin 
J Pain 31, 294–303 (2015).
 38. Ylinen, J., Nikander, R., Nykänen, M., Kautiainen, H. & Häkkinen, A. Effect of neck exercises on cervicogenic headache: a 
randomized controlled trial. J Rehabil Med 42, 344–349 (2010).
 39. Corey, D. L. & Comeau, D. Cervical radiculopathy. Med Clin North Am 98, 791–9, xii (2014).
 40. Corniola, M. V., Tessitore, E., Schaller, K. & Gautschi, O. P. [Cervical disc herniation–diagnosis and treatment]. Rev Med Suisse 11, 
2023–2029 (2015).
 41. Shabat, S., Leitner, Y., David, R. & Folman, Y. The correlation between Spurling test and imaging studies in detecting cervical 
radiculopathy. J Neuroimaging 22, 375–378 (2012).
 42. Schneider, B., Zheng, P., Mattie, R. & Kennedy, D. J. Safety of epidural steroid injections. Expert Opin Drug Saf 15, 1031–1039 (2016).
 43. Grifka, J., Boluki, D., Linhardt, O., Matussek, J. & Anders, S. Minimal-invasive Therapie bei Zervikalsyndromen. Der Orthopäde 36, 
59–65 (2007).
 44. Candido, K. D. & Knezevic, N. Cervical epidural steroid injections for the treatment of cervical spinal (neck) pain. Curr Pain 
Headache Rep 17, 314 (2013).
 45. Jacobson, E. in Relaxation as a therapy (Klett-Cotta, Stuttgart, 1990).
 46. Cramer, H., Lauche, R., Langhorst, J., Dobos, G. J. & Michalsen, A. Validation of the German version of the Neck Disability Index 
(NDI). BMC Musculoskelet Disord 15, 91 (2014).
 47. Copay, A. G., Glassman, S. D., Subach, B. R. & Berven, S. et al. Minimum clinically important difference in lumbar spine surgery 
patients: a choice of methods using the Oswestry Disability Index, Medical Outcomes Study questionnaire Short Form 36, and pain 
scales. Spine J 8, 968–974 (2008).
 48. Lee, J. S., Hobden, E., Stiell, I. G. & Wells, G. A. Clinically important change in the visual analog scale after adequate pain control. 
Acad Emerg Med 10, 1128–1130 (2003).
 49. Childs, J. D., Piva, S. R. & Fritz, J. M. Responsiveness of the numeric pain rating scale in patients with low back pain. Spine (Phila Pa 
1976) 30, 1331–1334 (2005).
 50. Dworkin, R. H., Turk, D. C., Farrar, J. T. & Haythornthwaite, J. A. et al. Core outcome measures for chronic pain clinical trials: 
IMMPACT recommendations. Pain 113, 9–19 (2005).
 51. Ritchie, C., Hendrikz, J., Kenardy, J. & Sterling, M. Derivation of a clinical prediction rule to identify both chronic moderate/severe 
disability and full recovery following whiplash injury. Pain 154, 2198–2206 (2013).
 52. Vernon, H. & Mior, S. The Neck Disability Index: a study of reliability and validity. J Manipulative Physiol Ther 14, 409–415 (1991).
 53. Schellingerhout, J. M., Heymans, M. W., Verhagen, A. P. & de Vet, H. C. et al. Measurement properties of translated versions of neck-
specific questionnaires: a systematic review. BMC Med Res Methodol 11, 87 (2011).
 54. Schellingerhout, J. M., Verhagen, A. P., Heymans, M. W. & Koes, B. W. et al. Measurement properties of disease-specific 
questionnaires in patients with neck pain: a systematic review. Qual Life Res 21, 659–670 (2012).
 55. Jorritsma, W., Dijkstra, P. U., de Vries, G. E., Geertzen, J. H. & Reneman, M. F. Detecting relevant changes and responsiveness of 
Neck Pain and Disability Scale and Neck Disability Index. Eur Spine J 21, 2550–2557 (2012).
 56. Herrmann, C. International experiences with the Hospital Anxiety and Depression Scale–a review of validation data and clinical 
results. J Psychosom Res 42, 17–41 (1997).
 57. Herrmann, C., Buss, U., Lingen, R. & Kreuzer, H. [The screening for anxiety and depression in routine medical care]. Dtsch Med 
Wochenschr 119, 1283–1286 (1994).
 58. Shakir, A., Ma, V. & Mehta, B. Comparison of pain score reduction using triamcinolone vs. dexamethasone in cervical 
transforaminal epidural steroid injections. Am J Phys Med Rehabil 92, 768–775 (2013).
 59. Lenzi, J., Nardone, A., Passacantilli, E., Caporlingua, A. et al. Posterior cervical transfacet fusion with facetal spacer for the treatment 
of single-level cervical radiculopathy: a randomized controlled prospective study. World Neurosurg (2017).
 60. Schneider, M. Pharmaceutical drug approval of corticosteroids for epidural spinal injections. Orthopädische und Unfallchirurgische 
Praxis 4(9) (2015).
 61. Engel, A., King, W. & MacVicar, J. & Standards Division of the International Spine Intervention Society The effectiveness and risks 
of fluoroscopically guided cervical transforaminal injections of steroids: a systematic review with comprehensive analysis of the 
published data. Pain Med 15, 386–402 (2014).
 62. Manchikanti, L., Cash, K. A., Pampati, V., Wargo, B. W. & Malla, Y. A randomized, double-blind, active control trial of fluoroscopic 
cervical interlaminar epidural injections in chronic pain of cervical disc herniation: results of a 2-year follow-up. Pain Physician 16, 
465–478 (2013).
 63. Lee, J. H. & Lee, S. H. Can repeat injection provide clinical benefit in patients with cervical disc herniation and stenosis when the 
first epidural injection results only in partial response? Medicine (Baltimore) 95, e4131 (2016).
 64. Sadacharam, K., Petersohn, J. D. & Green, M. S. Inadvertent Subdural Injection during Cervical Transforaminal Epidural Steroid 
Injection. Case Rep Anesthesiol 2013, 847085 (2013).
 65. Gitkind, A. I., Olson, T. R. & Downie, S. A. Vertebral artery anatomical variations as they relate to cervical transforaminal epidural 
steroid injections. Pain Med 15, 1109–1114 (2014).
 66. Wolff, M. W. & Levine, L. A. Cervical radiculopathies: conservative approaches to management. Phys Med Rehabil Clin N Am 13, 
589–608, vii (2002).
 67. Swezey, R. L., Swezey, A. M. & Warner, K. Efficacy of home cervical traction therapy. Am J Phys Med Rehabil 78, 30–32 (1999).
 68. Fritz, J. M., Thackeray, A., Brennan, G. P. & Childs, J. D. Exercise only, exercise with mechanical traction, or exercise with over-door 
traction for patients with cervical radiculopathy, with or without consideration of status on a previously described subgrouping rule: 
a randomized clinical trial. J Orthop Sports Phys Ther 44, 45–57 (2014).
 69. Hasenbring, M., Hallner, D. & Klasen, B. [Psychological mechanisms in the transition from acute to chronic pain: over- or 
underrated?]. Schmerz 15, 442–447 (2001).
www.nature.com/scientificreports/
9SCientifiC RepoRts | 7: 7866  | DOI:10.1038/s41598-017-08350-x
 70. Manchikanti, L., Candido, K. D., Singh, V. & Gharibo, C. G. et al. Epidural steroid warning controversy still dogging FDA. Pain 
Physician 17, E451–E474 (2014).
 71. U.S. Food and Drug Administration FDA requires label changes to warn of rare but serious neurologic problems after epidural 
corticosteroid injections for pain. www.fda.gov/downloads/Drugs/DrugSafety/UCM394286.pdf.
 72. Derby, R., Lee, S. H., Date, E. S., Lee, J. H. & Lee, C. H. Size and aggregation of corticosteroids used for epidural injections. Pain Med 
9, 227–234 (2008).
 73. Okubadejo, G. O., Talcott, M. R., Schmidt, R. E. & Sharma, A. et al. Perils of intravascular methylprednisolone injection into the 
vertebral artery. An animal study. J Bone Joint Surg Am 90, 1932–1938 (2008).
Acknowledgements
We are grateful to Monika C Schoell for medical editing.
Author Contributions
A.B., M.B., T.R., M.W., J.G., F.V. and D.B. made substantial contributions to the conception and design of the 
study. M.B., F.Z., M.W., F.V. and A.B. participated in the acquisition of data, analysis and statistics. All authors 
made contributions to the interpretation of data and have been involved in drafting the manuscript. All authors 
read and approved the final manuscript.
Additional Information
Competing Interests: The authors declare that they have no competing interests.
Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and 
institutional affiliations.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International 
License, which permits use, sharing, adaptation, distribution and reproduction in any medium or 
format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Cre-
ative Commons license, and indicate if changes were made. The images or other third party material in this 
article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the 
material. If material is not included in the article’s Creative Commons license and your intended use is not per-
mitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the 
copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
 
© The Author(s) 2017
